A decade of molecular pathogenomic analysis of group A Streptococcus.
James M Musser, Samuel A Shelburne
https://pubmed.ncbi.nlm.nih.gov/19729843/Actively Recruiting
Led by University of Wisconsin, Madison · Updated on 2026-02-18
180
Participants Needed
1
Research Sites
N/A
Total Duration
This research aims to understand why some children become carriers of Group A streptococcus GAS and whether those carriers need antibiotic treatment. The study focuses on differences in GAS bacteria between children with acute infection and those who carry the bacteria without symptoms. Researchers will examine genetic and transcriptional changes in the bacteria to learn how it behaves in these two states. Children aged 5 to 15 years with acute pharyngitis caused by GAS are eligible. Participants will be tested using a rapid antigen detection test and throat cultures at study entry, after 14 days, and again after 14 to 21 days if initial follow-up tests are positive. The study involves collecting samples to analyze the bacterias gene expression and genome. Participants will undergo throat swabs and sample collections at specified times to identify who are carriers of GAS. Researchers will measure the presence of GAS bacteria and study their genetic profiles over time. The studys main outcome is identifying children who carry GAS bacteria in their throat after initial infection. The total participation time is around two weeks for primary outcome measurement.
CONDITIONS
GRoup A StrePtococcus
C
Cherie Schommer, BA
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Wisconsin, Madison
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Approximately 4 to 6 weeks
Participants are observed to identify children who are pharyngeal carriers of Group A streptococcus by collecting throat swabs and analyzing bacterial gene expression.
Visits at study entry, at 14 days, and if follow-up is positive, again in 14 to 21 days
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
James M Musser, Samuel A Shelburne
https://pubmed.ncbi.nlm.nih.gov/19729843/Jun Li, Hui Jiang, Wing Hung Wong
https://pubmed.ncbi.nlm.nih.gov/20459815/A L Bisno
https://pubmed.ncbi.nlm.nih.gov/11172144/Jonathan R Carapetis, Andrew C Steer, E Kim Mulholland...
https://pubmed.ncbi.nlm.nih.gov/16253886/Simon Anders, Wolfgang Huber
https://pubmed.ncbi.nlm.nih.gov/20979621/M E Pichichero
https://pubmed.ncbi.nlm.nih.gov/9745311/Hui Jiang, Wing Hung Wong
https://pubmed.ncbi.nlm.nih.gov/19244387/University of Wisconsin, Madison
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborating Sponsor